NR1H4 and metabolic dysfunction-associated steatotic liver disease: This study aimed to reveal the regulatory mechanisms of cholesterol-lowering (CL) probiotics on NAFLD from aspects involved in BA metabolism in FXR gene knockout (FXR−/−) mice.